Therapeutic enhancement of radiation and immunomodulation by gold nanoparticles in triple negative breast cancer

References

• Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer. 2005;104(6):1129–1137. doi:10.1002/cncr.21324.
   PubMed Web of Science ®Google Scholar
• Atun R, Jaffray DA, Barton MB, Bray F, Baumann M, Vikram B, Hanna TP, Knaul FM, Lievens Y, Lui TYM, et al. Expanding global access to radiotherapy. Lancet Oncol. 2015;16(10):1153–1186. doi:10.1016/S1470-2045(15)00222-3.
   PubMed Web of Science ®Google Scholar
• Rosa S, Connolly C, Schettino G, Butterworth KT, Prise KM. Biological mechanisms of gold nanoparticle radiosensitization. Cancer Nanotechnol. 2017;8(1):2. doi:10.1186/s12645-017-0026-0.
   PubMed Web of Science ®Google Scholar
• Bentzen SM. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer. 2006;6(9):702–713. doi:10.1038/nrc1950.
   PubMed Web of Science ®Google Scholar
• Wolff D, Stieler F, Welzel G, Lorenz F, Abo-Madyan Y, Mai S, Herskind C, Polednik M, Steil V, Wenz F, et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiotherapy Oncol. 2009;93(2):226–233. doi:10.1016/j.radonc.2009.08.011.
   PubMed Web of Science ®Google Scholar
• Linam J, Yang LX. Recent developments in radiosensitization. Anticancer Res. 2015;35(5):2479–2485.
   PubMed Web of Science ®Google Scholar
• He C, Chow JCL. Gold nanoparticle DNA damage in radiotherapy: A Monte Carlo study. Vol. 3. AIMS Bioengineering: AIMS Bioengineering; 2016.
   Google Scholar
• Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol. 2004;49(18):N309–315. doi:10.1088/0031-9155/49/18/N03.
   PubMed Web of Science ®Google Scholar
• Kong T, Zeng J, Wang X, Yang X, Yang J, McQuarrie S, McEwan A, Roa W, Chen J, Xing JZ, et al. Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles. Small (Weinheim an Der Bergstrasse, Germany). 2008;4(9):1537–1543. doi:10.1002/smll.200700794.
   PubMed Web of Science ®Google Scholar
• Butterworth KT, McMahon SJ, Taggart LE, Prise KM. Radiosensitization by gold nanoparticles: effective at megavoltage energies and potential role of oxidative stress. Transl Cancer Res. 2013;2(4):269–279.
   Web of Science ®Google Scholar
• Butterworth KT, McMahon SJ, Currell FJ, Prise KM. Physical basis and biological mechanisms of gold nanoparticle radiosensitization. Nanoscale. 2012;4(16):4830–4838. doi:10.1039/c2nr31227a.
   PubMed Web of Science ®Google Scholar
• Jeremic B, Aguerri AR, Filipovic N. Radiosensitization by gold nanoparticles. Clin Transl Oncol. 2013;15(8):593–601. doi:10.1007/s12094-013-1003-7.
   PubMed Web of Science ®Google Scholar
• Schuemann J, Berbeco R, Chithrani DB, Cho SH, Kumar R, McMahon SJ, Sridhar S, Krishnan S. Roadmap to clinical use of gold nanoparticles for radiation sensitization. Int J Radiat Oncol Biol Phys. 2016;94(1):189–205. doi:10.1016/j.ijrobp.2015.09.032.
   PubMed Web of Science ®Google Scholar
• Hainfeld JF, Dilmanian FA, Zhong Z, Slatkin DN, Kalef-Ezra JA, Smilowitz HM. Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma. Phys Med Biol. 2010;55(11):3045–3059. doi:10.1088/0031-9155/55/11/004.
   PubMed Web of Science ®Google Scholar
• Janic B, Liu F, Bobbitt K, L Brown S, J Chetty I, Mao G, Movsas B, Wen N. Cellular uptake and radio-sensitization effect of small gold nanoparticles in MCF-7 breast cancer cells. J Nanomed Nanotechnol. 2018;9(3):3. doi:10.4172/2157-7439.1000499.
   Google Scholar
• Luo D, Wang X, Zeng S, Ramamurthy G, Burda C, Basilion JP. Targeted gold nanocluster-enhanced radiotherapy of prostate cancer. Small (Weinheim an Der Bergstrasse, Germany). 2019;15(34):e1900968. doi:10.1002/smll.201900968.
   PubMed Web of Science ®Google Scholar
• Chithrani DB, Jelveh S, Jalali F, van Prooijen M, Allen C, Bristow RG, Hill RP, Jaffray DA. Gold nanoparticles as radiation sensitizers in cancer therapy. Radiat Res. 2010;173(6):719–728. doi:10.1667/RR1984.1.
   PubMed Web of Science ®Google Scholar
• Cui L, Her S, Borst GR, Bristow RG, Jaffray DA, Allen C. Radiosensitization by gold nanoparticles: will they ever make it to the clinic? Radiotherapy Oncol. 2017;124(3):344–356. doi:10.1016/j.radonc.2017.07.007.
   PubMed Web of Science ®Google Scholar
• Cui L, Tse K, Zahedi P, Harding SM, Zafarana G, Jaffray DA, Bristow RG, Allen C. Hypoxia and cellular localization influence the radiosensitizing effect of gold nanoparticles (AuNPs) in breast cancer cells. Radiat Res. 2014;182(5):475–488. doi:10.1667/RR13642.1.
   PubMed Web of Science ®Google Scholar
• Taggart LE, McMahon SJ, Currell FJ, Prise KM, Butterworth KT. The role of mitochondrial function in gold nanoparticle mediated radiosensitisation. Cancer Nanotechnol. 2014;5(1):5. doi:10.1186/s12645-014-0005-7.
   PubMedGoogle Scholar
• Galluzzi L, Buque A, Kepp O, Zitvogel L, Kroemer G. Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol. 2017;17(2):97–111. doi:10.1038/nri.2016.107.
   PubMed Web of Science ®Google Scholar
• Demaria S, Golden EB, Formenti SC. Role of Local Radiation Therapy in Cancer Immunotherapy. JAMA oncol. 2015;1(9):1325–1332. doi:10.1001/jamaoncol.2015.2756.
   PubMed Web of Science ®Google Scholar
• Reits EA, Hodge JW, Herberts CA, Groothuis TA, Chakraborty M, K.Wansley E, Camphausen K, Luiten RM, de Ru AH, Neijssen J, et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med. 2006;203(5):1259–1271. doi:10.1084/jem.20052494.
   PubMed Web of Science ®Google Scholar
• Burnette BC, Liang H, Lee Y, Chlewicki L, Khodarev NN, Weichselbaum RR, Fu Y-X, Auh SL. The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity. Cancer Res. 2011;71(7):2488–2496. doi:10.1158/0008-5472.CAN-10-2820.
   PubMed Web of Science ®Google Scholar
• Voorwerk L, Slagter M, Horlings HM, Sikorska K, van de Vijver KK, de Maaker M, Nederlof I, Kluin RJC, Warren S, Ong S, et al. Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial. Nat Med. 2019;25(6):920–928. doi:10.1038/s41591-019-0432-4.
   PubMed Web of Science ®Google Scholar
• Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, Apetoh L, Aranda F, Barnaba V, Bloy N, et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology. 2014;3(9): e955691-e955691 e955691. doi:10.4161/21624011.2014.955691.
   PubMed Web of Science ®Google Scholar
• Lwin Z-M, Guo C, Salim A, Yip GWC, Chew F-T, Nan J, Thike AA, Tan P-H, Bay B-H. Clinicopathological significance of calreticulin in breast invasive ductal carcinoma. Modern Pathol. 2010;23(12):1559. doi:10.1038/modpathol.2010.173.
   PubMed Web of Science ®Google Scholar
• Dewan MZ, Galloway AE, Kawashima N, Dewyngaert JK, Babb JS, Formenti SC, Demaria S. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clini Cancer Res. 2009;15(17):5379–5388. doi:10.1158/1078-0432.CCR-09-0265.
   PubMed Web of Science ®Google Scholar
• Matsumura S, Wang B, Kawashima N, Braunstein S, Badura M, Cameron TO, Babb JS, Schneider RJ, Formenti SC, Dustin ML, et al. Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. J Immunol. 2008;181(5):3099–3107. doi:10.4049/jimmunol.181.5.3099.
   PubMed Web of Science ®Google Scholar
• Cui L, Her S, Dunne M, Borst GR, De Souza R, Bristow RG, Jaffray DA, Allen C. Significant radiation enhancement effects by gold nanoparticles in combination with cisplatin in triple negative breast cancer cells and tumor xenografts. Radiat Res. 2017;187(2):147–160. doi:10.1667/RR14578.1.
   PubMed Web of Science ®Google Scholar
• den Brok WD, Speers CH, Gondara L, Baxter E, Tyldesley SK, Lohrisch CA. Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed. Breast Cancer Res Treat. 2017;161(3):549–556. doi:10.1007/s10549-016-4080-9.
   PubMed Web of Science ®Google Scholar
• Albanese A, Tang PS, Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012;14:1–16. doi:10.1146/annurev-bioeng-071811-150124.
   PubMed Web of Science ®Google Scholar
• Alkilany AM, Murphy CJ. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanoparticle Res. 2010;12(7):2313–2333. doi:10.1007/s11051-010-9911-8.
   PubMed Web of Science ®Google Scholar
• Rossi G, Monticelli L. Gold nanoparticles in model biological membranes: A computational perspective. Biochimica Et Biophysica Acta (BBA) - Biomembranes. 2016;1858(10):2380–2389. doi:10.1016/j.bbamem.2016.04.001.
   PubMed Web of Science ®Google Scholar
• Khlebtsov N, Dykman L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev. 2011;40(3):1647–1671. doi:10.1039/C0CS00018C.
   PubMed Web of Science ®Google Scholar
• Beneduci A, Chidichimo G, Tripepi S, Perrotta E. Transmission electron microscopy study of the effects produced by wide-band low-power millimeter waves on MCF-7 human breast cancer cells in culture. Anticancer Res. 2005;25(2a):1009–1013.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, Chan TA, Coukos G, Demaria S, Deutsch E, et al. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. J Immunother Cancer. 2020;8:1. doi:10.1136/jitc-2019-000337.
   Web of Science ®Google Scholar
• Anders CK, Carey LA. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer. Clin Breast Cancer. 2009;9(Suppl 2):S73–81. doi:10.3816/CBC.2009.s.008.
   PubMed Web of Science ®Google Scholar
• Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363(20):1938–1948. doi:10.1056/NEJMra1001389.
   PubMed Web of Science ®Google Scholar
• Nedeljkovic M, Damjanovic A. Mechanisms of chemotherapy resistance in triple-negative breast cancer-how we can rise to the challenge. Cells. 2019;8:9. doi:10.3390/cells8090957.
   Web of Science ®Google Scholar
• Eiermann W, Vallis KA. Locoregional treatments for triple-negative breast cancer. Ann Oncol. 2012;23(Suppl 6):vi30–34. doi:10.1093/annonc/mds192.
   PubMedGoogle Scholar
• Perrault SD, Walkey C, Jennings T, Fischer HC, Chan WC. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett. 2009;9(5):1909–1915. doi:10.1021/nl900031y.
   PubMed Web of Science ®Google Scholar
• Dimitriou NM, Tsekenis G, Balanikas EC, Pavlopoulou A, Mitsiogianni M, Mantso T, Pashos G, Boudouvis AG, Lykakis IN, Tsigaridas G, et al. Gold nanoparticles, radiations and the immune system: current insights into the physical mechanisms and the biological interactions of this new alliance towards cancer therapy. Pharmacol Ther. 2017;178:1–17. doi:10.1016/j.pharmthera.2017.03.006.
   PubMed Web of Science ®Google Scholar
• Chithrani BD, Ghazani AA, Chan WC. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006;6(4):662–668. doi:10.1021/nl052396o.
   PubMed Web of Science ®Google Scholar
• Chithrani BD, Chan WCW. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 2007;7(6):1542–1550. doi:10.1021/nl070363y.
   PubMed Web of Science ®Google Scholar
• Pan Y, Leifert A, Ruau D, Neuss S, Bornemann J, Schmid G, Brandau W, Simon U, Jahnen-Dechent W. Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small (Weinheim an Der Bergstrasse, Germany). 2009;5(18):2067–2076. doi:10.1002/smll.200900466.
   PubMed Web of Science ®Google Scholar
• Hvolbæk B, Janssens TVW, Clausen BS, Falsig H, Christensen CH, Nørskov JK. Catalytic activity of Au nanoparticles. Nano Today. 2007;2(4):14–18. doi:10.1016/S1748-0132(07)70113-5.
   Web of Science ®Google Scholar
• Simpson CA, Huffman BJ, Gerdon AE, Cliffel DE. Unexpected toxicity of monolayer protected gold clusters eliminated by PEG-thiol place exchange reactions. Chem Res Toxicol. 2010;23(10):1608–1616. doi:10.1021/tx100209t.
   PubMed Web of Science ®Google Scholar
• Gilles M, Brun E, Sicard-Roselli C. Gold nanoparticles functionalization notably decreases radiosensitization through hydroxyl radical production under ionizing radiation. Colloids Surf B Biointerfaces. 2014;123:770–777. doi:10.1016/j.colsurfb.2014.10.028.
   PubMed Web of Science ®Google Scholar
• Senut MC, Zhang Y, Liu F, Sen A, Ruden DM, Size-Dependent MG. Toxicity of gold nanoparticles on human embryonic stem cells and their neural derivatives. Small (Weinheim an Der Bergstrasse, Germany). 2016;12(5):631–646. doi:10.1002/smll.201502346.
   PubMed Web of Science ®Google Scholar
• Minic Z, Zhang Y, Mao G, Goshgarian HG. Transporter protein-coupled DPCPX nanoconjugates induce diaphragmatic recovery after SCI by blocking adenosine A1 receptors. J Neurosci. 2016;36(12):3441–3452. doi:10.1523/JNEUROSCI.2577-15.2016.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Walker JB, Minic Z, Liu F, Goshgarian H, Mao G. Transporter protein and drug-conjugated gold nanoparticles capable of bypassing the blood-brain barrier. Sci Rep. 2016;6(1):25794. doi:10.1038/srep25794.
   PubMedGoogle Scholar
• Berry CC, de la Fuente JM, Mullin M, Chu SW, Curtis AS. Nuclear localization of HIV-1 tat functionalized gold nanoparticles. IEEE Trans Nanobioscience. 2007;6(4):262–269. doi:10.1109/TNB.2007.908973.
   PubMed Web of Science ®Google Scholar
• Beck M, Forster F, Ecke M, et al. Nuclear pore complex structure and dynamics revealed by cryoelectron tomography. Science. 2004;306(5700):1387–1390. doi:10.1126/science.1104808.
   PubMed Web of Science ®Google Scholar
• Kodiha M, Mahboubi H, Maysinger D, Stochaj U. Gold nanoparticles impinge on nucleoli and the stress response in MCF7 BREAST CANCER CELLS. Nanobiomedicine. 2016;3:3. doi:10.5772/62337.
   PubMedGoogle Scholar
• Albanese A, Chan W. Effect of gold nanoparticle aggregation on cell uptake and toxicity. ACS Nano. 2011;5:5478–5489. doi:10.1021/nn2007496.
   PubMed Web of Science ®Google Scholar
• Rizk N, Christoforou N, Lee S. Optimization of anti-cancer drugs and a targeting molecule on multifunctional gold nanoparticles. Nanotechnology. 2016;27(18):185704. doi:10.1088/0957-4484/27/18/185704.
   PubMed Web of Science ®Google Scholar
• Yao X, Huang C, Chen X, Yi Z, Sanche L. Chemical radiosensitivity of DNA induced by gold nanoparticles. J Biomed Nanotechnol. 2015;11(3):478–485. doi:10.1166/jbn.2015.1922.
   PubMed Web of Science ®Google Scholar
• Sia J, Szmyd R, Hau E, Gee HE. Molecular mechanisms of radiation-induced cancer cell death: a primer. Frontiers Cell Dev Bio. 2020;8:41. doi:10.3389/fcell.2020.00041.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay N, Cai Z, Kwon YL, Lechtman E, Pignol JP, Reilly RM. Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation. Breast Cancer Res Treat. 2013;137(1):81–91. doi:10.1007/s10549-012-2338-4.
   PubMed Web of Science ®Google Scholar
• Zhang X-D, Wu D, Shen X, Chen J, Sun Y-M, Liu P-X, Liang X-J. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials. 2012;33(27):6408–6419. doi:10.1016/j.biomaterials.2012.05.047.
   PubMed Web of Science ®Google Scholar
• Hainfeld JF, Smilowitz HM, O’Connor MJ, Dilmanian FA, Slatkin DN. Gold nanoparticle imaging and radiotherapy of brain tumors in mice. Nanomedicine. 2013;8(10):1601–1609. doi:10.2217/nnm.12.165.
   PubMed Web of Science ®Google Scholar
• Wolfe T, Chatterjee D, Lee J, Grant JD, Bhattarai S, Tailor R, Goodrich G, Nicolucci P, Krishnan S. Targeted gold nanoparticles enhance sensitization of prostate tumors to megavoltage radiation therapy in vivo. Nanomedicine: Nanotechnology, Biology and Medicine. 2015;11(5):1277–1283. doi:10.1016/j.nano.2014.12.016.
   PubMed Web of Science ®Google Scholar
• Herold DM, Das IJ, Stobbe CC, Iyer RV, Chapman JD. Gold microspheres: a selective technique for producing biologically effective dose enhancement. Int J Radiat Biol. 2000;76(10):1357–1364. doi:10.1080/09553000050151637.
   PubMed Web of Science ®Google Scholar
• Chang MY, Shiau AL, Chen YH, Chang CJ, Chen HH, Wu CL. Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice. Cancer Sci. 2008;99(7):1479–1484. doi:10.1111/j.1349-7006.2008.00827.x.
   PubMed Web of Science ®Google Scholar
• Hébert EM, Debouttière P-J, Lepage M, Sanche L, Hunting DJ, Hebert EM, Debouttiere PJ, Lepage M, Sanche L, Hunting DJ. Preferential tumour accumulation of gold nanoparticles, visualised by Magnetic Resonance Imaging: radiosensitisation studies in vivo and in vitro. Int J Radiat Biol. 2010;86(8):692–700. doi:10.3109/09553001003746067.
   PubMed Web of Science ®Google Scholar
• Joh DY, Sun L, Stangl M, Al Zaki A, Murty S, Santoiemma PP, Davis JJ, Baumann BC, Alonso-Basanta M, Bhang D, et al. Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization. PLoS One. 2013;8(4):e62425. doi:10.1371/journal.pone.0062425.
   PubMed Web of Science ®Google Scholar
• De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJ, Geertsma RE. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials. 2008;29(12):1912–1919. doi:10.1016/j.biomaterials.2007.12.037.
   PubMed Web of Science ®Google Scholar
• Zhang G, Yang Z, Lu W, Zhang R, Huang Q, Tian M, Li L, Liang D, Li C. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials. 2009;30(10):1928–1936. doi:10.1016/j.biomaterials.2008.12.038.
   PubMed Web of Science ®Google Scholar
• Hainfeld JF, Dilmanian FA, Slatkin DN, Smilowitz HM. Radiotherapy enhancement with gold nanoparticles. J Pharm Pharmacol. 2008;60(8):977–985. doi:10.1211/jpp.60.8.0005.
   PubMed Web of Science ®Google Scholar
• Kim JH, Kolozsvary A, Jenrow KA, Brown SL. Plerixafor, a CXCR4 antagonist, mitigates skin radiation-induced injury in mice. Radiat Res. 2012;178(3):202–206. doi:10.1667/RR2886.1.
   PubMed Web of Science ®Google Scholar
• Charaghvandi RK, Yoo S, van Asselen B, Rodrigues A, van den Bongard D, Horton JK. Treatment constraints for single dose external beam preoperative partial breast irradiation in early-stage breast cancer. Clini Trans Radiat Oncol. 2017;6:7–14. doi:10.1016/j.ctro.2017.06.003.
   PubMed Web of Science ®Google Scholar
• Palta M, Yoo S, Adamson JD, Prosnitz LR, Horton JK. Preoperative single fraction partial breast radiotherapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2012;82(1):37–42. doi:10.1016/j.ijrobp.2010.09.041.
   PubMed Web of Science ®Google Scholar
• Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, Mulroy L, Lock M, Rodrigues GB, Yaremko BP, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet. 2019;393(10185):2051–2058. doi:10.1016/S0140-6736(18)32487-5.
   PubMed Web of Science ®Google Scholar
• Theelen W, Peulen HMU, Lalezari F, van der Noort V, de Vries JF, Aerts JGJV, Dumoulin DW, Bahce I, Niemeijer ALN, de Langen AJ, et al. Effect of pembrolizumab after stereotactic body radiotherapy vs pembrolizumab alone on tumor response in patients with advanced non-small cell lung cancer: results of the PEMBRO-RT phase 2 randomized clinical trial. JAMA oncol. 2019;5:1276. doi:10.1001/jamaoncol.2019.1478.
   PubMed Web of Science ®Google Scholar
• Hall EJ, Giaccia AJ. Radiobiology for the Radiologist. 8 ed. Lippincott Williams & Wilkins (LWW); 2018. ISBN: 978–1–49–633541–8
   Google Scholar
• Shultz LD, Goodwin N, Ishikawa F, Hosur V, Lyons BL, Greiner DL. Human cancer growth and therapy in immunodeficient mouse models. Cold Spring Harb Protoc. 2014;2014(7):694–708. doi:10.1101/pdb.top073585.
   PubMedGoogle Scholar
• Kelland LR. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development. European J Cancer (Oxford, England: 1990). 2004;40(6):827–836. doi:10.1016/j.ejca.2003.11.028.
   PubMed Web of Science ®Google Scholar
• Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini J-L, Castedo M, Mignot G, Panaretakis T, Casares N, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med. 2007;13(1):54–61. doi:10.1038/nm1523.
   PubMed Web of Science ®Google Scholar
• Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation. Nature. 2015;517(7534):311–320. doi:10.1038/nature14191.
   PubMed Web of Science ®Google Scholar
• Eriksson D, Stigbrand T. Radiation-induced cell death mechanisms. Tumour Biol. 2010;31(4):363–372. doi:10.1007/s13277-010-0042-8.
   PubMedGoogle Scholar
• McQuaid HN, Muir MF, Taggart LE, McMahon SJ, Coulter JA, Hyland WB, Jain S, Butterworth KT, Schettino G, Prise KM, et al. Imaging and radiation effects of gold nanoparticles in tumour cells.. Scientific Reports. 2016;6:19442. doi:10.1038/srep19442.
   PubMed Web of Science ®Google Scholar
• Ma Y, Kepp O, Ghiringhelli F, Apetoh L, Aymeric L, Locher C, Tesniere A, Martins I, Ly A, Haynes NM, et al. Chemotherapy and radiotherapy: cryptic anticancer vaccines. Semin Immunol. 2010;22(3):113–124. doi:10.1016/j.smim.2010.03.001.
   PubMed Web of Science ®Google Scholar
• Turkevich J, Stevenson PC, Hillier JA, Study of the nucleation and growth processes in the synthesis of. Gold C. Discuss Faraday Soc. 1951;11:55-&. doi:10.1039/df9511100055.
   Google Scholar
• Controlled FG. Nucleation for regulation of particle-size in monodisperse gold suspensions. Nature-Phys Sci. 1973;241(105):20–22. doi:10.1038/physci241020a0.
   Web of Science ®Google Scholar
• Kimling J, Maier M, Okenve B, Kotaidis V, Ballot H, Plech A. Turkevich method for gold nanoparticle synthesis revisited. J Phys Chem B. 2006;110(32):15700–15707. doi:10.1021/jp061667w.
   PubMed Web of Science ®Google Scholar
• Bankhead P, Loughrey MB, Fernández JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7(1):16878. doi:10.1038/s41598-017-17204-5.
   PubMedGoogle Scholar